Business/ News Measurements Network
The Glenn Mark Pharmaceuticals Company has received the final approval from the U.S. Department of Food and Drug Administration Controller Department (US FDA) to bring some medicines to the market. After this news, shares of Glen Mark rose by 3.31 per cent. The pharmaceutical manufacturer has informed the stock market regulator in this context. Glenmark Pharmaceuticals has received the approval of the ANDA. Informing BSE and NSE, Glen Marc Forma has said that the US FDA has given final approval for the company's hydro-cortison valverate event USP (0.2 percent) to the US market. This is the generic version of Sun Fertilizer Industries, Inc.'s WestCort Event (0.2 percent). The pharma company said that the sales growth of the company during the year ending October 2018 has increased.
According to the data of the sales report of the IQVITM, the sales of WestCort plasters have increased by 0.2 percent. The pharmaceutical manufacturer in the US market has achieved the annual sales target of approximately $ 11.1 million. In the current portfolio of Glenn Mark, the US Contains 145 products authorized for distribution. However, the company has applied 55 products to the ANDA for clearance to bring it into the market with the American FDA